Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic-Myeloproliferative Diseases

Explore clinical trials studying Myelodysplastic-Myeloproliferative Diseases. Study availability and eligibility vary by location and protocol.

387 public trials 62 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic-Myeloproliferative Diseases trial results

Completed

Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications

NCT00799461

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +154 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer

NCT00002504

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Bloomington Hospital Bloomington, Indiana, United States
  • St. Vincent Hospital and Health Care Center Research Department Indianapolis, Indiana, United States
  • Bergan Mercy Medical Center Omaha, Nebraska, United States
View Trial Details
Completed

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

NCT00003661

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +54 more
Locations
  • University of Florida Health Science Center Gainesville, Florida, United States
  • Division of Pediatric Surgery Jacksonville, Florida, United States
  • Nemours Children's Clinic Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
View all 17 locations
View Trial Details
Completed

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

NCT00361049

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +84 more
Locations
  • Geauga Regional Hospital Cleveland, Ohio, United States
  • Lake/University Ireland Cancer Center Cleveland, Ohio, United States
  • Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • University Suburban Health Center Cleveland, Ohio, United States
View Trial Details
Completed

Standard Follow-up Compared With Extended Follow-up in Treating Patients Who Have Undergone Stem Cell Transplantation for Cancer

NCT00049465

Conditions
Adnexal Diseases, Behavior, Behavioral Symptoms, +105 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • AMC Cancer Research Center Denver, Colorado, United States
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States
View Trial Details
Completed

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

NCT00045292

Conditions
Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +108 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Center at Stanford University Medical Center Stanford, California, United States
  • UNMC Eppley Cancer Center at the University of Nebraska Medical Center Omaha, Nebraska, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details

Related conditions